Jaguar Health (JAGX) EBT Margin Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 9,237.00 |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 441.00 |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -408.00 |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 6,591.00 |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 7,297.00 |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.76 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 8,952.00 |
| Jun 30, 2025 | -3,302.00 |
| Mar 31, 2025 | 9.03 Mn |
| Dec 31, 2024 | 39,672.00 |
| Sep 30, 2024 | 166,001.00 |
| Jun 30, 2024 | 336,146.00 |
| Mar 31, 2024 | 59,565.00 |
| Dec 31, 2023 | -6,433.00 |
| Sep 30, 2023 | 6.02 Mn |
| Jun 30, 2023 | 6.55 Mn |
| Mar 31, 2023 | -2.66 Mn |
| Dec 31, 2022 | -2.46 Mn |
| Sep 30, 2022 | 37,298.00 |
| Jun 30, 2022 | 51,552.00 |
| Mar 31, 2022 | -9.03 Mn |
| Dec 31, 2021 | 10,455.00 |
| Sep 30, 2021 | -144,021.00 |
| Jun 30, 2021 | -283,383.00 |